Stacie Phan, MBA, MS

Stacie Phan, MBA, MS, is president of the Biosimilars Forum. Ms. Phan has more than 20 years of experience in pharmaceutical research, government affairs, public policy analysis, and business operations. Currently she is Director of State Government Affairs and Public Policy, serving as Boehringer Ingelheim’s state government relations lead and key strategist for researching and developing company positions on public policy issues in the United States. Previously, Ms. Phan worked at Bayer HealthCare in public policy including reimbursement policy, oncology, and hemophilia.

US Physicians Need Better Education on Biosimilars

We need a medical community that is fully educated about the benefits of biosimilars so that the promise of these drugs can be fully realized in the United States.

Nov 17, 2017 @01:46 PM

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512

P: 609-716-7777
F: 609-716-4747